that elevation of some NF-κB inhibitors ,such as osteoprotegerin (OPG), are associated with elevated mortality, especially from cardiovascular diseases.[57][58] Elevated NF-κB has also been associated with schizophrenia.[59] Recently, NF-κB activation has been suggested as a possible molecular mechanism for the catabolic effects of cigarette smoke in skeletal muscle and sarcopenia.